Results 131 to 140 of about 8,275 (209)

Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer. [PDF]

Front Pharmacol
Schuch JB, Botton MR, De Baumont AC, Curzel G, Cadore NA, Bordignon C, Rosa ML, Vasconcellos VF, Barros LAR, Souza CP, Barra WF, Louzeiro DLC, Notari A, de Menezes JJ, Liedke PER, Bertollo GA, Gongora ABL, Ascenco HG, Kowalski-Neto E, Oppermann CP, Werutsky G, Santos EM, Brandão FS, Freitas-Junior R, Nogueira-Rodrigues A, Mancini ALC, Bessel M, Macedo GS, Rosa DD.   +28 more
europepmc   +1 more source

Addressing genetic diversity and health inequities: RELIVAF's proposal for Latin American pharmacogenomic guidelines. [PDF]

Front Pharmacol
Quiñones LA, Martínez MF, Vargas R, Cerpa LC, López-Cortés A, González-Martínez F, Fonseca D, Duconge J, Varela NM, Lares-Asseff I, Redal MA, Esperón P, Ríos-Santos F, Rendón AL, Serrano R, Ortega E, Sullón-Dextre L, Sanchez E, Arias ML, Remírez D, Morales A.   +20 more
europepmc   +1 more source

Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease. [PDF]

Int J Mol Sci
Tavano F, Palmieri O, Latiano M, Gioffreda D, Latiano T, Guerra M, Martino G, Valvano MR, Bossa F, Perri F, Latiano A.   +10 more
europepmc   +1 more source

Cyclopropylmethyl <i>S</i>-adenosyl-l-methionine: an enzymatic cyclopropylmethyl donor. [PDF]

Chem Sci
Zhao H, Yu N, Wang S, Dong M.
europepmc   +1 more source

Intestinal anti-inflammatory drug targets as potential modifiers of cardiovascular disease risk. [PDF]

J Pharm Anal
Tong S, Ye J, Lyu Y, Su J, Yan B, Cai X, Khan BA, Ud Din MA, Hou K, Li J.   +9 more
europepmc   +1 more source

Exploration of propionate metabolism-related genes to predict prognosis and immunotherapy response in ovarian cancer. [PDF]

J Ovarian Res
Ni J, Qiu J, Ma Y.
europepmc   +1 more source

Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource. [PDF]

Aliment Pharmacol Ther
Roberts C, Peters J, Sazonvos A, Goodman N, Sharip M, Smith R, Bishara M, Bewshea C, Lin S, Chanchlani N, Hodges P, Badrulhisham F, Saifuddin A, Carlson S, Centritto A, Marley A, Saad M, Sethi-Aora K, White L, Abdelmeguid A, Pele L, Sebastian S, Selinger C, Irving P, Fachal L, Walker G, Palmer R, Kennedy N, Houghton J, Doona M, Lamb C, Hyde C, Parkes M, Goodhand J, Ahmad T.   +34 more
europepmc   +1 more source

Pharmacokinetics of 6-thioguanine nucleotide and 6-methyl-mercaptopurine in a case of inadvertent combination therapy of azathioprine with allopurinol [PDF]

, 2012
Alves, Atecla N. L.,, Chocair, Pedro R., Duley, John A., Fortini, Alexandre S., Mendes, Maria E., Nahas, William C., Pacheco-Neto, Maurílio, Sumita, Nairo M., Torres, Larissa H. L.   +8 more
core  

Ecuador genetic mosaic: biological and adaptive variations across Mestizos, Native Amerindians, and Afro-Ecuadorians. Implications for public health and precision medicine. [PDF]

Front Genet
González-Andrade F.
europepmc   +1 more source

A case report of azathioprine-induced recurrent acute pancreatitis associated with high levels of 6-thioguanine nucleotides in a renal transplant recipient [PDF]

, 2012
Alves, Atecla N. L., Chocair, Pedro R., Duley, John A., Fortini, Alexandre S., Mendes, Maria E., Nahas, William C., Pacheco-Neto, Maurílio, Sumita, Nairo M., Torres, Larissa H. L.   +8 more
core